|
Market Closed -
Nasdaq
21:00:00 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 25.06 USD | -14.67% |
|
-11.54% | -17.40% |
| 10-20 | Health Care Up on Defensive Bias - Health Care Roundup | DJ |
| 10-20 | Raymond James Adjusts Rapport Therapeutics Price Target to $86 From $75, Maintains Strong Buy Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RAPP | Delayed | |
CBOE
| RAPP | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 33.91 | 33.91 | 48.77 |
| Spread/Res. | -26.10% | -26.10% | -48.62% |
| Spread/Supp. | +8.53% | +19.62% | +2.83% |
| Support | 23.09 | 20.95 | 24.37 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RAPP Stock
- Charts Rapport Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
